NO20061138L - Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi - Google Patents

Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi

Info

Publication number
NO20061138L
NO20061138L NO20061138A NO20061138A NO20061138L NO 20061138 L NO20061138 L NO 20061138L NO 20061138 A NO20061138 A NO 20061138A NO 20061138 A NO20061138 A NO 20061138A NO 20061138 L NO20061138 L NO 20061138L
Authority
NO
Norway
Prior art keywords
glycemia
hyperglycemia
prevention
treatment
stabilize
Prior art date
Application number
NO20061138A
Other languages
English (en)
Norwegian (no)
Inventor
Lucien Lesaffre
Original Assignee
Lesaffre & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesaffre & Cie filed Critical Lesaffre & Cie
Publication of NO20061138L publication Critical patent/NO20061138L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20061138A 2003-08-11 2006-03-09 Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi NO20061138L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018222 2003-08-11
EP03020253 2003-09-08
PCT/EP2004/008933 WO2005021015A1 (fr) 2003-08-11 2004-08-10 Ecorces de levures pour le traitement ou la prevention de l’hyperglycemie ou pour la stabilisation de la glycemie

Publications (1)

Publication Number Publication Date
NO20061138L true NO20061138L (no) 2006-05-10

Family

ID=34276722

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061138A NO20061138L (no) 2003-08-11 2006-03-09 Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi

Country Status (17)

Country Link
US (2) US7459159B2 (pt)
EP (1) EP1663266B1 (pt)
JP (2) JP4808619B2 (pt)
KR (1) KR101076209B1 (pt)
AU (1) AU2004267928B2 (pt)
BR (1) BRPI0413481A (pt)
CA (1) CA2534791C (pt)
DK (1) DK1663266T3 (pt)
EA (1) EA009677B1 (pt)
ES (1) ES2405934T3 (pt)
MA (1) MA28072A1 (pt)
MX (1) MXPA06001741A (pt)
NO (1) NO20061138L (pt)
NZ (1) NZ545594A (pt)
PL (1) PL1663266T3 (pt)
PT (1) PT1663266E (pt)
WO (1) WO2005021015A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006117566A (ja) * 2004-10-20 2006-05-11 Asahi Breweries Ltd 糖代謝改善剤
JP2007195444A (ja) * 2006-01-26 2007-08-09 Asahi Food & Healthcare Ltd ダイエット飲食品
AU2006347421A1 (en) * 2006-08-24 2008-02-28 Kirin Holdings Kabushiki Kaisha Composition for improving skin condition
JP5238166B2 (ja) * 2007-02-02 2013-07-17 株式会社ヤクルト本社 インターロイキン１２産生抑制剤
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2949064B1 (fr) 2009-08-14 2011-10-07 Lesaffre & Cie Nouvelles compositions destinees a la prevention et/ou au traitement du diabete
FR2978967B1 (fr) * 2011-08-09 2020-03-20 Lesaffre Et Compagnie Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede
MD4216C1 (ro) * 2012-08-15 2013-11-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Tulpină de drojdii Saccharomyces cerevisiae - producătoare de manani
EP3443849A4 (en) * 2016-04-14 2020-01-15 TableMark Co., Ltd. FOOD COMPOSITION OR COMBINATION FOR LOWERING THE GLYCEMIA RATE OR REDUCING THE IG VALUE
CN109310725A (zh) * 2016-05-17 2019-02-05 兴人生命科学株式会社 具有糖尿病预防效果的酵母提取物
IT201600069379A1 (it) * 2016-07-04 2018-01-04 Prosol S P A Composizione sostanzialmente costituita da pareti cellulari di lievito e procedimento per la sua preparazione
EP3685681B1 (en) 2019-01-23 2024-07-31 Lesaffre et Compagnie A yeast product, and a composition comprising it, for use as a prebiotic agent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
JPS61167622A (ja) * 1985-01-22 1986-07-29 Asahi Breweries Ltd 糖尿病コントロ−ル剤
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
ES2206500T3 (es) * 1993-12-28 2004-05-16 Societe Des Produits Nestle S.A. Producto alimenticio de cereales con gran contenido de fibra soluble.
DE4413023A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Gewinnung eines Faktors mit insulinartiger Wirkung aus Hefeextrakt
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5773426A (en) * 1996-06-07 1998-06-30 Masaki Shirota Proteoglucan and antidiabetic drug thereof
DK0928196T3 (da) * 1996-09-25 2004-04-26 Gracelinc Ltd Ekstraktionsprocesser for beta-glucan fra cerealier samt beta-glucanprodukter
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
FR2800076B1 (fr) 1999-10-22 2003-11-14 Lesaffre & Cie Mannoproteines solubles
WO2002002645A1 (en) * 2000-07-03 2002-01-10 Granate Seed Limited COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME
CN100391439C (zh) * 2001-04-27 2008-06-04 味之素株式会社 免疫增强剂
FR2825004B1 (fr) * 2001-05-22 2005-02-11 Bio Springer Produit dietetique satiant
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk MEDICINE AGAINST DIABETES
US20030118989A1 (en) * 2001-12-21 2003-06-26 Carsten Rosenow Differential isolation of cellular content for biological assays

Also Published As

Publication number Publication date
WO2005021015A1 (fr) 2005-03-10
KR20060037432A (ko) 2006-05-03
MXPA06001741A (es) 2006-05-12
AU2004267928A1 (en) 2005-03-10
EA009677B1 (ru) 2008-02-28
US20090022758A1 (en) 2009-01-22
MA28072A1 (fr) 2006-08-01
CA2534791A1 (fr) 2005-03-10
PT1663266E (pt) 2013-04-30
NZ545594A (en) 2009-09-25
EA200600402A1 (ru) 2006-08-25
EP1663266B1 (fr) 2013-02-20
JP2011178794A (ja) 2011-09-15
EP1663266A1 (fr) 2006-06-07
ES2405934T3 (es) 2013-06-04
BRPI0413481A (pt) 2006-10-17
CA2534791C (fr) 2014-10-28
JP2007501829A (ja) 2007-02-01
US20060257422A1 (en) 2006-11-16
AU2004267928B2 (en) 2010-10-21
KR101076209B1 (ko) 2011-10-24
PL1663266T3 (pl) 2013-07-31
JP4808619B2 (ja) 2011-11-02
US7459159B2 (en) 2008-12-02
DK1663266T3 (da) 2013-05-13

Similar Documents

Publication Publication Date Title
NO20061138L (no) Gjaercellevegger for behandling eller forebygging av hyperglukemi eller for a stabilisere glukemi
MX349188B (es) Sns - 595 y metodos para utilizar el mismo.
MX2007005590A (es) Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas.
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
NO20050795L (no) Forbindelser, blandinger og fremgangsmater for utnyttelse av samme
DE60238058D1 (de) Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau
MX345056B (es) Diagnóstico y tratamiento de deficiencia de sulfatasa múltiple y otras deficiencias de sulfatasa.
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
DE60330485D1 (de) Zur behandlung von diabetes
ATE447574T1 (de) 3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
NO20050717L (no) Metode og sammensetninger for modulering av T hjelpe (TH) celleutvikling og funksjon
EP1581169A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES RELATED TO NATURAL K CELLS
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
ATE458731T1 (de) Pyrimidin-derivate zur behandlung von anormalem zellwachstum
DE60232245D1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
TNSN06030A1 (en) Substituted thiazole-benzoisothiazole dioxide derivavites, method for the production thereof and use of the same
DE60329533D1 (de) Cyclische sulfamide zur inhibierung von gamma-sekretase
NO20044534L (no) Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer
NO20064584L (no) Tetrahydropyridoindolderivater
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
WO2003103581A3 (en) COMPOSITIONS AND METHODS FOR LIVER GROWTH AND PROTECTION
DK1237549T3 (da) Lipoxin A4 og dets analoger til behandling af törre öjne
NO20076405L (no) Anvendelse av 24-nor-UDCA
NO20054670D0 (no) Behandling av intestinale tilstander med N-2,3,3-tetrametylbisyklo[2.2.1]-heptan-2-amid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application